Clinical Study for Kypha Complement Activation Assays
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to determine if a new test for measuring certain proteins associated with tissue inflammation (called the COMP ACT assay) can measure these proteins in adults.
Description
The purpose of this study is to evaluate in vitro complement activation in the clinical laboratory workflow and to assess the performance of this new test's sample stablization buffer to prevent in vitro complement activation.
Details
| Condition | autoimmune disease |
|---|---|
| Age | 18years - 99years |
| Clinical Study Identifier | TX5828 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.